rethinkPeptides Search
Menu
Research citation

Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD).

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD).

Journal of clinical medicine, 13(20)

Citation

Dusilová, Tereza; Kovář, Jan; Laňková, Ivana; Thieme, Lenka; Hubáčková, Monika; Šedivý, Petr; Pajuelo, Dita; Burian, Martin; Dezortová, Monika; Miklánková, Denisa; Malínská, Hana; Svobodová Šťastná, Petra; Poledne, Rudolf; Hájek, Milan; Haluzík, Martin. (2024). Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD).. Journal of clinical medicine, 13(20). https://doi.org/10.3390/jcm13206100